Shares in Endocyte Inc. (Nasdaq: ECYT) are no longer considered a penny stock after sgreeing to a deal with Merck & Co. today. Vintafolide, Endocyte’s experimental ovarian cancer treatment is in the third of three stages of FDA testing and Merck decided to jump on it. The deal could be worth $1 billion for the company.
Shares in, what was a penny stock before the market open,
Continue Reading →
16
APR
0
Share
